# Glycopyrrolate

NDC: 0781-3829
Generic name: Glycopyrrolate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20190722

FDA application: ANDA211334

## Active ingredients

- GLYCOPYRROLATE: 1 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-3829"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-3829
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb1ae370-ec4f-4114-9860-8f736f72b545